Back
Black Diamond Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
BDTX
Black Diamond Therapeutics
Last Price:
$3.22
Seasonality Move:
-29.92%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDTX is experiencing slight selling pressure.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.77 | Buy |
| 20-day SMA: | 2.57 | Buy |
| 50-day SMA: | 2.29 | Buy |
| 200-day SMA: | 2.39 | Buy |
| 8-day EMA: | 2.82 | Buy |
| 20-day EMA: | 2.63 | Buy |
| 50-day EMA: | 2.37 | Buy |
| 200-day EMA: | 2.59 | Buy |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 73.35 | Buy |
| Chaikin Money Flow: | -976989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 2.75) | Buy |
| Bollinger Bands (100): | (1.56 - 2.42) | Buy |
Black Diamond Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 3.04 while BDTX 8-day simple moving average is 2.77, which is a Buy signal.
-
The stock price of BDTX is 3.04 while Black Diamond Therapeutics 20-day SMA is 2.57, which makes it a Buy.
-
Black Diamond Therapeutics 50-day simple moving average is 2.29 while BDTX share price is 3.04, making it a Buy technically.
-
BDTX stock price is 3.04 and Black Diamond Therapeutics 200-day simple moving average is 2.39, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Buy
59
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a BuyThe current Black Diamond Therapeutics [BDTX] share price is $3.04. The Score for BDTX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
172.9M
Price in USD:
3.04
Share Volume:
2.3M
Black Diamond Therapeutics 52-Week Range
52-Week High:
6.75
52-Week Low:
1.20
Buy
59
Black Diamond Therapeutics (BDTX)
is a Buy
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?The Black Diamond Therapeutics stock price is 3.04 USD today.
-
Will BDTX stock go up or go down?Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Black Diamond Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is not overvalued.
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 3.04 while BDTX 8-day exponential moving average is 2.82, which is a Buy signal.
-
The stock price of BDTX is 3.04 while Black Diamond Therapeutics 20-day EMA is 2.63, which makes it a Buy.
-
Black Diamond Therapeutics 50-day exponential moving average is 2.37 while BDTX share price is 3.04, making it a Buy technically.
-
BDTX stock price is 3.04 and Black Diamond Therapeutics 200-day simple moving average is 2.59, creating a Buy signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.08 per share, an increase this year of $1.53 per share, and a decrease next year of $0.97 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
-
BDTX Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting Black Diamond Therapeutics is a Buy
-
Black Diamond Therapeutics Relative Strength Index (RSI) is 73.35, which suggest Black Diamond Therapeutics is overbought
-
The Bollinger Bands (25) for Black Diamond Therapeutics is (2.33 - 2.75), which suggest Black Diamond Therapeutics is a Buy
-
The Bollinger Bands (100) for Black Diamond Therapeutics is (1.56 - 2.42), which suggest Black Diamond Therapeutics is a Buy
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.